Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Its once-weekly injection design gives it a clear advantage over older amylin analogs like pramlintide, which required multiple daily doses
Example Calculation Contexts Example math only
CJC-1295 Best for: Sustained growth-hormone-axis stimulation for lean mass and recovery support CJC-1295 is a synthetic growth-hormone-releasing hormone (GHRH) analog, a modified 29-amino-acid peptide originally developed by ConjuChem Biotechnologies
21 NiemeyerP.PestkaJ
Common in-vitro readouts include scratch-wound migration assays and angiogenesis tube-formation assays, alongside investigations of fibroblast behavior and nitric-oxide and growth-factor pathways
It regulates actin (the structural protein inside your cells), promotes stem cell migration toward damaged tissue, and supports new blood vessel formation on a systemic level
